Engineered cell therapy for cancer gets thumbs up from FDA advisers

Heidi Ledford

Nature, 2017, vol. 547, issue 7663, 270-270

Abstract: Treatment shows promise in young people with leukaemia, but safety risks abound.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature.2017.22304 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:547:y:2017:i:7663:d:10.1038_nature.2017.22304

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature.2017.22304

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().